Coloplast Names New Leader

Coloplast’s Board of Directors has appointed Gavin Wood as president and CEO of the Coloplast Group to succeed interim CEO Lars Rasmussen, who has been in charge since May 5, 2025.

Wood has spent two decades in different leadership roles at Johnson & Johnson, most recently as company Group Chairman of Johnson & Johnson MedTech EMEA, a multi-billion-dollar business with more than 7,000 employees working across three business units: Surgery, Orthopedics, and Cardiovascular & Specialty Solutions.

“On behalf of the Board of Directors, I am very pleased to welcome Gavin Wood to Coloplast. Gavin is a seasoned medtech executive with an impressive track record when it comes to creating value and driving growth,” Interim Board Chair Jette Nygaard-Andersen said. “Gavin has a strong commercial profile and valuable experience from multiple companies in the medtech space. He has led global commercial organizations, and he has an in-depth understanding of both the European and U.S. healthcare markets. The board is confident that Gavin is the right candidate to lead the company into its next chapter of growth and value creation by delivering on the Impact4 strategy together with the rest of the executive leadership team.”

Earlier in his career, Wood led the Ethicon Wound Closure & Healing team as worldwide president, and before that, he was executive vice president, Commercial, at Mölnlycke. He currently serves as vice chair of MedTech Europe.

Wood earned a bachelor of arts degree in law from Carleton University, Canada, and an MBA from Queen’s University, Canada. He is Canadian and will be relocating to Denmark.  

“I’m very excited to join Coloplast. The company has a rich history, strong innovation portfolio, and a clear mission to help people live better lives. I look forward to driving continued growth of the business, investing in talent, and delivering on the Impact4 strategy to generate value and impact for all our stakeholders, customers, users, and patients in the future,” Wood stated.    

Founded in Denmark in 1957, Coloplast is now a global company with more than 17,000 employees in 43 countries. The company currently focuses on a range of intimate healthcare needs, including ostomy care, continence care, interventional urology, wound and tissue repair, and voice and respiratory care. Its products help more than 2 million people worldwide.